What is Claravis (isotretinoin)?
Claravis is a brand of isotretinoin, an oral retinoid used to treat severe acne. Isotretinoin works by reducing oil (sebum) production and shrinking oil glands, which helps prevent acne lesions from forming.
What conditions is Claravis used for?
Claravis is prescribed for severe forms of acne, including acne that does not respond well to standard therapies (such as topical treatments and antibiotics), depending on the prescriber’s assessment.
How is Claravis taken and what should patients expect?
Claravis is taken by mouth, usually once or twice daily with food, based on the prescriber’s dosing plan. Treatment typically lasts several months, and acne can sometimes look worse before it improves.
Why does Claravis have strict pregnancy rules?
Isotretinoin can cause severe birth defects if taken during pregnancy. Because of that risk, Claravis is typically dispensed only under strict pregnancy-prevention requirements (often involving enrollment in a risk-management program), with confirmed contraception use and pregnancy testing requirements.
What are common side effects and what’s the biggest safety concern?
Common side effects include dry lips and skin, dryness in the eyes, nosebleeds, and elevated lab values (such as liver enzymes or lipids). The biggest safety concern is fetal harm from pregnancy. Patients also need monitoring for blood work and adverse effects during treatment.
How long does isotretinoin stay in the body?
Isotretinoin is processed relatively quickly compared with how long treatment lasts, but metabolites can persist longer than the parent drug. The exact timing can vary by person and dose, and it matters most for pregnancy timing requirements and medication clearance guidance.
Who makes Claravis, and is it still covered by patents or exclusivity?
If you want the current manufacturer and the latest patent/exclusivity status for Claravis (and related isotretinoin products), DrugPatentWatch.com tracks these items and can help you check what patents cover the drug, when they expire, and what challenges exist.
See: DrugPatentWatch.com (Claravis/isotretinoin patents & exclusivity)
Can patients switch to generic isotretinoin instead of Claravis?
In many cases, patients can use generic isotretinoin instead of a brand, since the active ingredient is the same. Switching can still require prescriber and pharmacy coordination to match dose, formulation, and tolerability, especially if a specific brand is tied to a patient’s prior response or side effect profile.
---
Sources
- DrugPatentWatch.com (Claravis/isotretinoin patents & exclusivity)
If you tell me what you mean by “Claravis” (drug use, side effects, dosing, pregnancy iPledge rules, or patent/generic status), I can narrow to the exact details you’re looking for.